B95.62 Methicillin resistant Staphylococcus aureus infection as the cause of diseases classified elsewhere

Name of the Condition

• Methicillin resistant Staphylococcus aureus infection as the cause of diseases classified elsewhere (ICD Code B95.62)

Summary

This condition refers to infections caused by methicillin-resistant Staphylococcus aureus (MRSA) bacteria, which contribute to diseases classified under other primary conditions. MRSA is a type of staph bacteria resistant to many antibiotics, including methicillin, and can lead to infections in various body sites, such as skin, bloodstream, or surgical sites, depending on the context and severity.

Causes

Methicillin-resistant Staphylococcus aureus (MRSA) bacteria are responsible. These bacteria are commonly found on the skin or in the nose and can cause disease when they enter normally sterile areas or when the immune system is compromised. Transmission occurs through direct contact, contaminated surfaces, or healthcare-associated exposures.

Risk Factors

• Hospitalization or long-term care facility stays
• Recent surgery or invasive procedures
• Use of medical devices (e.g., catheters, ventilators)
• Compromised immune systems (e.g., diabetes, cancer, HIV)
• Chronic skin conditions or wounds
• Prolonged antibiotic use

Symptoms

• Symptoms vary by infection site and may include fever, chills, pain, redness, swelling, or discharge. For example, skin infections may present with pus or abscesses, while bloodstream infections can cause sepsis.

Diagnosis

Diagnosis involves identifying MRSA as the causative agent in infections classified under other primary conditions. This typically requires laboratory testing, such as cultures or molecular assays, to confirm the presence of MRSA and its resistance profile.

Treatment Options

Treatment depends on the infection site and severity. Options may include antibiotics effective against MRSA (e.g., vancomycin, linezolid) and supportive care, such as wound management or drainage of abscesses. In severe cases, hospitalization may be necessary.

Prognosis and Follow-Up

Prognosis varies based on the infection site, patient health, and timely treatment. Early intervention improves outcomes, but severe infections can lead to complications. Follow-up may involve monitoring for recurrence or resistance and adjusting treatment as needed.

Complications

• Sepsis or septic shock
• Deep tissue infections (e.g., osteomyelitis, endocarditis)
• Recurrent infections
• Antibiotic resistance

Lifestyle & Prevention

• Practice good hand hygiene, especially in healthcare settings
• Keep wounds clean and covered
• Avoid sharing personal items (e.g., towels, razors)
• Follow infection control guidelines in hospitals or clinics

When to Seek Professional Help

Seek medical attention if you experience signs of infection, such as fever, increasing pain, redness, or swelling, especially if you have risk factors for MRSA. Prompt care is important for severe or worsening symptoms.

Tips for Medical Coders

When coding B95.62, ensure the underlying condition (classified elsewhere) is documented, and MRSA is confirmed as the cause. Documentation should specify the infection site and any relevant antibiotic resistance details to support accurate coding.